| Peter Stuart Boone, MD | |
|
888 White Plains Rd Ste 106, Trumbull, CT 06611-4552 | |
| (203) 268-2882 | |
| (203) 601-8551 |
| Full Name | Peter Stuart Boone |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 888 White Plains Rd Ste 106, Trumbull, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093741654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 032386 (Connecticut) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 032386 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Orthopaedic Specialists Pc | 7315850039 | 154 |
| Rehabilitation Associates Inc | 8022905322 | 297 |
News Archive
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
The American College of Rheumatology today applauded the leadership of Rep. David McKinley and Rep. G.K. Butterfield in reintroducing H.R. 2999, the Patients' Access to Treatment Act.
LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.
› Verified 7 days ago
| Entity Name | Connecticut Orthopaedic Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235181389 PECOS PAC ID: 7315850039 Enrollment ID: O20031110000220 |
News Archive
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
The American College of Rheumatology today applauded the leadership of Rep. David McKinley and Rep. G.K. Butterfield in reintroducing H.R. 2999, the Patients' Access to Treatment Act.
LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.
› Verified 7 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
The American College of Rheumatology today applauded the leadership of Rep. David McKinley and Rep. G.K. Butterfield in reintroducing H.R. 2999, the Patients' Access to Treatment Act.
LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.
› Verified 7 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
The American College of Rheumatology today applauded the leadership of Rep. David McKinley and Rep. G.K. Butterfield in reintroducing H.R. 2999, the Patients' Access to Treatment Act.
LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Stuart Boone, MD 2408 Whitney Ave, Hamden, CT 06518-3209 Ph: (203) 626-0160 | Peter Stuart Boone, MD 888 White Plains Rd Ste 106, Trumbull, CT 06611-4552 Ph: (203) 268-2882 |
News Archive
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
The American College of Rheumatology today applauded the leadership of Rep. David McKinley and Rep. G.K. Butterfield in reintroducing H.R. 2999, the Patients' Access to Treatment Act.
LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.
› Verified 7 days ago
David Jon Martin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-601-8585 | |
Dr. Curtis Lyle Campbell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 | |
Kelms Amoo-achampong, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 888 White Plains Rd Ste 105&106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 | |
Dr. Michael R Redler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-445-5572 | |
John V Mangieri, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 160 Hawley Lane, Trumbull, CT 06611 Phone: 203-381-9670 Fax: 203-381-9669 | |
Dr. Alim Ramji, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 White Plains Rd Ste 105&106, Trumbull, CT 06611 Phone: 203-268-2882 Fax: 203-452-3099 |